Evidence map›Paper›PMID 33057738›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2021

Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures.

E V McCloskey, N C Harvey, H Johansson, M Lorentzon, L Vandenput, E Liu, J A Kanis

Abstract read
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019-2023.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Article
  6. Review
  7. Article
  8. Social determinants of health inequity in Iran: a narrative review.Journal of diabetes and metabolic disorders · 2023
    Review
  9. Health literacy status of pregnant women and women with young children in Tasmania.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2023
    Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Epidemiology and economic burden of fragility fractures in Austria.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Article
  15. Review
  16. Review
  17. Osteoporosis care amidst the prolonged pandemic.Journal of endocrinological investigation · 2021
    Review
  18. Article
  19. How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

E V McCloskeyDepartment of Oncology and Metabolism, Academic Unit of Bone Metabolism, Metabolic Bone Centre, Northern General Hospital, Centre for Integrated Research in Musculoskeletal Ageing, Mellanby Centre for Bone Research, University of Sheffield, Sheffield, S5 7AU, UK. e.v.mccloskey@shef.ac.uk.ORCID http://orcid.org/0000-0003-0177-8140
N C HarveyMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
H JohanssonCentre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
M LorentzonMary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
L VandenputMary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
E LiuMary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
J A KanisCentre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.

Funding

Medical Research Council MC_PC_21003Medical Research Council MR/P020941/1
6 · The paper itself

Abstract

The COVID-19 pandemic, and its management, is markedly impacting the management of osteoporosis as judged by access to online FRAX fracture risk assessments. Globally, access was 58% lower in April than in February 2020. Strategies to improve osteoporosis care, with greater use of fracture risk assessments, offer a partial solution.

introductionThe COVID-19 pandemic is having a significant detrimental impact on the management of chronic diseases including osteoporosis. We have quantified the global impact by examining changes in the usage of online FRAX fracture risk assessments before and after the declaration of the pandemic (11 March 2020).

methodsThe study comprised a retrospective analysis using GoogleAnalytics data on daily sessions on the FRAX® website ( www.sheffield.ac.uk/FRAX ) from November 2019 to April 2020 (main analysis period February-April 2020), and the geographical source of that activity.

resultsOver February-April 2020, the FRAX website recorded 460,495 sessions from 184 countries, with 210,656 sessions in February alone. In March and April, the number of sessions fell by 23.1% and 58.3% respectively, a pattern not observed over the same period in 2019. There were smaller reductions in Asia than elsewhere, partly related to earlier and less-marked nadirs in some countries (China, Taiwan, Hong Kong, South Korea and Vietnam). In Europe, the majority of countries (24/31, 77.4%) reduced usage by at least 50% in April. Seven countries showed smaller reductions (range - 2.85 to - 44.1%) including Poland, Slovakia, Czech Republic, Germany, Norway, Sweden and Finland. There was no significant relationship between the reduction in FRAX usage and measures of disease burden such as COVID-attributed deaths per million of the population.

conclusionThis study documents a marked global impact of the COVID-19 pandemic on the management of osteoporosis as reflected by FRAX online fracture risk assessments. The analysis suggests that impact may relate to the societal and healthcare measures taken to ameliorate the pandemic.

Indexed as

COVID-19Disease ManagementGlobal HealthHumansInternetOsteoporosisOsteoporotic FracturesPandemicsRetrospective StudiesRisk AssessmentCOVID-19FractureFRAXNon-communicable diseases (NCD)Osteoporosis

Identifiers

PMID33057738
PMCPMC7556595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.